Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma

Author:

Sonpavde Guru P.1,Mariani Luigi2,Lo Vullo Salvatore2,Raggi Daniele2,Giannatempo Patrizia2,Bamias Aristotle3,Crabb Simon J.4,Bellmunt Joaquim5,Yu Evan Y.6,Niegisch Guenter7,Vaishampayan Ulka N.8,Theodore Christine9,Berthold Dominik R.10,Srinivas Sandy11,Sridhar Srikala S.12,Plimack Elizabeth R.13,Rosenberg Jonathan E.14,Powles Thomas15,Galsky Matthew D.16,Necchi Andrea2

Affiliation:

1. Dana-Farber Cancer Institute, Boston, Massachusetts

2. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

3. University of Athens, Athens, Greece

4. University of Southampton, Southampton

5. Hospital del Mar Medical Research Institute, Barcelona, Spain

6. University of Washington, Seattle, Washington

7. Department of Urology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany

8. Karmanos Cancer Center, Wayne State University, Detroit, Michigan

9. Hospital Foch, Suresnes, France

10. Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

11. Stanford University, Stanford, California

12. Princess Margaret Hospital Cancer Center, Toronto, Ontario, Canada

13. Fox Chase Cancer Center, Philadelphia, Pennsylvania

14. Memorial Sloan Kettering Cancer Center, New York, New York

15. Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

16. Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3